Prometheus Biosciences CEO on the company's ability to raise capital, get FDA approval
Cramer spoke with Prometheus Biosciences CEO Mark McKenna on Friday.
UP NEXT
NOW PLAYING: Top Stocks
Prometheus Biosciences CEO on the company's ability to raise capital, get FDA approval
CNBC
UP NEXT
-
Bracing for another interest rate hike
KERO 23 Bakersfield, CA
-
San Diego businesses react to SDG&E's projected decline in natural gas prices
KGTV San Diego, CA
-
Alternative investing outlook: Ares' Arougheti on 2023 outlook
CNBC
-
Tour: LA's whispered $100 million penthouse condo
-
Some state buildings in downtown Sacramento to be turned into housing
CBS Sacramento -
Cramer's lightning round: CRISPR Therapeutics will work perfectly in this market
-
Pfizer CEO on the company's full-year forecast
-
Denton roads icy but busy
CBS Dallas -
Jim Cramer gives his take on Nordson's stock
-
GM CEO Barra on the company's pricing strategy
-
Jim Cramer on why investors should prepare themselves for down days
-
Cramer says to watch for buying opportunities in the current bull market
-
Food banks preparing for increase in need after extra SNAP benefits end
CBS Pittsburgh -
Matchmaker Sets Up 51-Year-Old Divorced Parents Who Are Looking To Start Their Life With Someone New
Dr. Phil
-
Bear market's final leg looms as weak earnings season, says Morgan Stanley's Mike Wilson
-
NH university, business leaders call for more education funding
WMUR Manchester
